Systems biology and synthetic biology: Understanding biological complexity on the critical path to personalized medicine

Current Pharmacogenomics and Personalized Medicine

Volumn 8, Issue 4, 2010, Pages 257-267

  Armengaud, Jean ^a  

^a DIF   (France)

Author keywords

Biological complexity; Biological noise; Multi omics; Personalized medicine; Phenomics; Proteogenomics; Synthetic biology; Systems biology

Indexed keywords

ARTICLE; DEINOCOCCUS; FEEDING BEHAVIOR; GENE PRODUCT; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME PROJECT; LINGUISTICS; MASS SPECTROMETRY; MEDLINE; MOLECULAR GENETICS; NONHUMAN; NUTRIGENOMICS; OBESITY; PERSONALIZED MEDICINE; PROTEOMICS;

EID: 80052257477     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569210793368186     Document Type: Article

References (112)

1. Friend SH. Breast cancer susceptibility testing: realities in the post-genomic era. Nat Genet 1996; 13(1): 16-7.
2. Lander ES, Weinberg RA. Genomics: journey to the center of biology. Science 2000; 287(5459): 1777-82.
3. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001; 2: 343-72.
4. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009; 1(1): 2.
5. Kitano H. Computational systems biology. Nature 2002; 420(6912): 206-10.
6. Brent R. A partnership between biology and engineering. Nat Biotechnol 2004; 22(10): 1211-4.
7. Barrett CL, Kim TY, Kim HU, et al. Systems biology as a foundation for genome-scale synthetic biology. Curr Opin Biotechnol 2006; 17(5): 488-92.
8. Gibson DG, Glass JI, Lartigue C, et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science 2010; 329(5987): 52-6.
9. Fleischmann RD, Adams MD, White O, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995; 269(5223): 496-512.
10. Dunham I, Shimizu N, Roe BA, et al. The DNA sequence of human chromosome 22. Nature 1999; 402(6761): 489-95.
11. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822): 860-921.
12. International HGSC. Finishing the euchromatic sequence of the human genome. Nature 2004; 431(7011): 931-45.
13. Bovee D, Zhou Y, Haugen E, et al. Closing gaps in the human genome with fosmid resources generated from multiple individuals. Nat Genet 2008; 40(1): 96-101.
14. Kyrpides NC. Fifteen years of microbial genomics: meeting the challenges and fulfilling the dream. Nat Biotechnol 2009; 27(7): 627-32.
15. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008; 9: 387-402.
16. Yooseph S, Sutton G, Rusch DB, et al. The Sorcerer II Global Ocean Sampling expedition: expanding the universe of protein families. PLoS Biol 2007; 5(3): e16.
17. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124(4): 837-48.
18. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449(7164): 804-10.
19. Nelson KE, Weinstock GM, Highlander SK, et al. A catalog of reference genomes from the human microbiome. Science 2010; 328(5981): 994-9.
20. Khaja R, Zhang J, MacDonald JR, et al. Genome assembly comparison identifies structural variants in the human genome. Nat Genet 2006; 38(12): 1413-8.
21. Roach JC, Glusman G, Smit AF, et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010; 328(5978): 636-9.
22. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010; 42(1): 30-5.
23. Blencowe BJ. Alternative splicing: new insights from global analyses. Cell 2006; 126(1): 37-47.
24. Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat Biotechnol 2004; 22(5): 535-46.
25. Ota T, Suzuki Y, Nishikawa T, et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 2004; 36(1): 40-5.
26. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004; 101(16): 6062-7.
27. Cenik C, Derti A, Mellor JC, et al. Genome-wide functional analysis of human 5' untranslated region introns. Genome Biol 2010; 11(3): R29.
28. Dieci G, Preti M, Montanini B. Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics 2009; 94(2): 83-8.
29. Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J 2001; 20(14): 3617-22.
30. Brosnan CA, Voinnet O. The long and the short of noncoding RNAs. Curr Opin Cell Biol 2009; 21(3): 416-25.
31. Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease. J Pathol 2010; 220(2): 126-39.
32. Dambach MD, Winkler WC. Expanding roles for metabolitesensing regulatory RNAs. Curr Opin Microbiol 2009; 12(2): 161-9.
33. Henkin TM. Riboswitch RNAs: using RNA to sense cellular metabolism. Genes Dev 2008; 22(24): 3383-90.
34. Gstaiger M, Aebersold R. Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat Rev Genet 2009; 10(9): 617-27.
35. Patterson SD, Aebersold RH. Proteomics: the first decade and beyond. Nat Genet 2003; 33(Suppl): 311-23.
36. Bowen BP, Northen TR. Dealing with the Unknown: Metabolomics and Metabolite Atlases. J Am Soc Mass Spectrom 2010; 21(9): 1471-6.
37. Collins MO, Choudhary JS. Mapping multiprotein complexes by affinity purification and mass spectrometry. Curr Opin Biotechnol 2008; 19(4): 324-30.
38. Krogan NJ, Cagney G, Yu H, et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006; 440(7084): 637-43.
39. Barglow KT, Cravatt BF. Activity-based protein profiling for the functional annotation of enzymes. Nat Methods 2007; 4(10): 822-7.
40. Beloqui A, Guazzaroni ME, Pazos F, et al. Reactome array: forging a link between metabolome and genome. Science 2009; 326(5950): 252-7.
41. Armengaud J. Proteogenomics and systems biology: quest for the ultimate missing parts. Expert Rev Proteomics 2010; 7(1): 65-77.
42. Wang Z, Gerstein M, Snyder M. RNA-seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10(1): 57-63.
43. Young NL, Plazas-Mayorca MD, Garcia BA. Systems-wide proteomic characterization of combinatorial post-translational modification patterns. Expert Rev Proteomics 2010; 7(1): 79-92.
44. Doucet A, Butler GS, Rodriguez D, et al. Metadegradomics: toward in vivo quantitative degradomics of proteolytic posttranslational modifications of the cancer proteome. Mol Cell Proteomics 2008; 7(10): 1925-51.
45. Kleifeld O, Doucet A, Keller U, et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 2010; 28(3): 281-8.
46. Schilling O, Barre O, Huesgen PF, et al. Proteome-wide analysis of protein carboxy termini: C terminomics. Nat Methods 2010; 7(7): 508-11.
47. Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet 2010; 11(7): 476-86.
48. Ansong C, Purvine SO, Adkins JN, et al. Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief Funct Genomic Proteomic 2008; 7(1): 50-62.
49. Armengaud J. A perfect genome annotation is within reach with the proteomics and genomics alliance. Curr Opin Microbiol 2009; 12(3): 292-300.
50. Baudet M, Ortet P, Gaillard JC, et al. Proteomics-based refinement of Deinococcus deserti genome annotation reveals an unwonted use of non-canonical translation initiation codons. Mol Cell Proteomics 2010; 9(2): 415-26.
51. Wildes D, Wells JA. Sampling the N-terminal proteome of human blood. Proc Natl Acad Sci USA 2010; 107(10): 4561-6.
52. de Groot A, Dulermo R, Ortet P, et al. Alliance of proteomics and genomics to unravel the specificities of Sahara bacterium Deinococcus deserti. PLoS Genet 2009; 5(3): e1000434.
53. Cobucci-Ponzano B, Guzzini L, Benelli D, et al. Functional characterization and high-throughput proteomic analysis of interrupted genes in the archaeon Sulfolobus solfataricus. J Proteome Res 2010; 9(5): 2496-507.
54. Denoeud F, Aury JM, Da Silva C, et al. Annotating genomes with massive-scale RNA sequencing. Genome Biol 2008; 9(12): R175.
55. Saha S, Sparks AB, Rago C, et al. Using the transcriptome to annotate the genome. Nat Biotechnol 2002; 20(5): 508-12.
56. Qiu Y, Cho BK, Park YS, et al. Structural and operational complexity of the Geobacter sulfurreducens genome. Genome Res 2010; 20(9): 1304-11.
57. Medina I, Carbonell J, Pulido L, et al. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 2010; 38(Suppl): W210-3.
58. Jensen LJ, Kuhn M, Stark M, et al. STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37: D412-6.
59. Jaffe JD, Stange-Thomann N, Smith C, et al. The complete genome and proteome of Mycoplasma mobile. Genome Res 2004; 14(8): 1447-61.
60. Zivanovic Y, Armengaud J, Lagorce A, et al. Genome analysis and genome-wide proteomics of Thermococcus gammatolerans, the most radioresistant organism known amongst the Archaea. Genome Biol 2009; 10(6): R70.
61. Li M, Gray W, Zhang H, et al. Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J Proteome Res 2010; in press.
62. Brun V, Masselon C, Garin J, et al. Isotope dilution strategies for absolute quantitative proteomics. J Proteomics 2009; 72(5): 740-9.
63. Malmstrom J, Beck M, Schmidt A, et al. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 2009; 460(7256): 762-5.
64. Paterson AH, Bowers JE, Bruggmann R, et al. The Sorghum bicolor genome and the diversification of grasses. Nature 2009; 457(7229): 551-6.
65. Mattick JS. Challenging the dogma: the hidden layer of nonproteincoding RNAs in complex organisms. Bioessays 2003; 25(10): 930-9.
66. Mattick JS, Taft RJ, Faulkner GJ. A global view of genomic information--moving beyond the gene and the master regulator. Trends Genet 2010; 26(1): 21-8.
67. Shapiro JA. Revisiting the central dogma in the 21st century. Ann N Y Acad Sci 2009; 1178: 6-28.
68. Grosjean H. Nucleic acids are not boring long polymers of only four types of nucleotides: a guided tour. In DNA and RNA Modification Enzymes: Structure, Mechanism, Function and Evolution., Grosjean H. Ed.; Landes Biosciences: Austin, Texas: 2009; pp. 1-18.
69. Caetano-Anollés G, Wang M, Caetano-Anollés D, et al. The origin, evolution and structure of the protein world. Biochem J 2009; 417(3): 621-37.
70. Forterre P, Prangishvili D. The great billion-year war between ribosomeand capsid-encoding organisms (cells and viruses) as the major source of evolutionary novelties. Ann N Y Acad Sci 2009; 1178: 65-77.
71. Glansdorff N, Xu Y, Labedan B. The last universal common ancestor: emergence, constitution and genetic legacy of an elusive forerunner. Biol Direct 2008; 3: 29.
72. Danchin A. Bacteria as computers making computers. FEMS Microbiol Rev 2009; 33(1): 3-26.
73. Danchin A. Information of the chassis and information of the program in synthetic cells. Syst Synth Biol 2009; 3(1-4): 125-34.
74. Van Etten JL, Lane LC, Dunigan DD. DNA viruses: the really big ones (giruses). Ann Rev Microbiol 2010; 64: 83-99.
75. Siefert JL. Defining the mobilome. Methods Mol Biol 2009; 532: 13-27.
76. Tenaillon O, Silander OK, Uzan JP, et al. Quantifying organismal complexity using a population genetic approach. PLoS One 2007; 2(2): e217.
77. Kirschner MW. The meaning of systems biology. Cell 2005; 121(4): 503-4.
78. Huberts DH, van der Klei IJ. Moonlighting proteins: an intriguing mode of multitasking. Biochim Biophys Acta 2009; 1803(4): 520-5.
79. Benner SA, Hutter D, Sismour AM. Synthetic biology with artificially expanded genetic information systems. From personalized medicine to extraterrestrial life. Nucleic Acids Res Suppl 2003; (3): 125-6.
80. Registry of Standard Biological Parts. Available at: http://partsregistry. org/Main_Page. [Accessed September 27, 2010].
81. Sinha J, Reyes SJ, Gallivan JP. Reprogramming bacteria to seek and destroy an herbicide. Nat Chem Biol 2010; 6(6): 464-70.
82. Lartigue C, Glass JI, Alperovich N, et al. Genome transplantation in bacteria: changing one species to another. Science 2007; 317(5838): 632-8.
83. Lartigue C, Vashee S, Algire MA, et al. Creating bacterial strains from genomes that have been cloned and engineered in yeast. Science 2009; 325(5948): 1693-6.
84. Ro DK, Paradise EM, Ouellet M, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006; 440(7086): 940-3.
85. Dietrich JA, Yoshikuni Y, Fisher KJ, et al. A novel semibiosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). ACS Chem Biol 2009; 4(4): 261-7.
86. Ro DK, Ouellet M, Paradise EM, et al. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial precursor, artemisinic acid. BMC Biotechnol 2008; 8: 83.
87. Weber W, Fussenegger M. The impact of synthetic biology on drug discovery. Drug Discov Today 2009; 14(19-20): 956-63.
88. Whitty A. Cooperativity and biological complexity. Nat Chem Biol 2008; 4(8): 435-9.
89. Fenton AW. Allostery: an illustrated definition for the 'second secret of life'. Trends Biochem Sci 2008; 33(9): 420-5.
90. Csete ME, Doyle JC. Reverse engineering of biological complexity. Science 2002; 295(5560): 1664-9.
91. Jostins L, Jaeger J. Reverse engineering a gene network using an asynchronous parallel evolution strategy. BMC Syst Biol 2010; 4: 17.
92. Simpson ML, Cox CD, Allen MS, et al. Noise in biological circuits. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1(2): 214-25.
93. Deribe YL, Pawson T, Dikic I. Post-translational modifications in signal integration. Nat Struct Mol Biol 2010; 17(6): 666-72.
94. Li X, Gerber SA, Rudner AD, et al. Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae. J Proteome Res 2007; 6(3): 1190-7.
95. Wilson-Grady JT, Villen J, Gygi SP. Phosphoproteome analysis of fission yeast. J Proteome Res 2008; 7(3): 1088-97.
96. Gnad F, Forner F, Zielinska DF, et al. Evolutionary constraints of phosphorylation in eukaryotes, prokaryotes and mitochondria. Mol Cell Proteomics 2010; in press.
97. Tan CS, Pasculescu A, Lin WA, et al. Positive selection of tyrosine loss in metazoan evolution. Science 2009; 325(5948): 1686-8.
98. Koomen JM, Haura EB, Bepler G, et al. Proteomic contributions to personalized cancer care. Mol Cell Proteomics 2008; 7(10): 1780-94.
99. Yang S, Huang CM. Recent advances in protein profiling of tissues and tissue fluids. Expert Rev Proteomics 2007; 4(4): 515-29.
100. Wisztorski M, Croix D, Macagno E, et al. Molecular MALDI imaging: an emerging technology for neuroscience studies. Dev Neurobiol 2008; 68(6): 845-58.
101. Hardesty WM, Caprioli RM. In situ molecular imaging of proteins in tissues using mass spectrometry. Anal Bioanal Chem 2008; 391(3): 899-903.
102. Collins BC, Lau TY, O'Connor DP, et al. Cancer proteomics-an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine. EMBO Rep 2009; 10(11): 1202-5.
103. Mouton-Barbosa E, Roux-Dalvai F, Bouyssie D, et al. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics 2006; 9(5): 1006-21.
104. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 2009; 3(1): 33-44.
105. Carey LA. Through a glass darkly: advances in understanding breast cancer biology, 2000-2010. Clin Breast Cancer 2010; 10(3): 188-95.
106. Hondermarck H, Tastet C, El Yazidi-Belkoura I, et al. Proteomics of breast cancer: the quest for markers and therapeutic targets. J Proteome Res 2008; 7(4): 1403-11.
107. Sandhu C, Connor M, Kislinger T, et al. Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells. J Proteome Res 2005; 4(3): 674-89.
108. Gonzalez-Angulo AM, Hennessy BT, Mills GB. Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol 2010; 28(16): 2777-83.
109. Valet G. Cytomics as a new potential for drug discovery. Drug Discov Today 2006; 11(17-18): 785-91.
110. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov 2002; 1(9): 727-30.
111. Jeffery DA, Bogyo M. Chemical proteomics and its application to drug discovery. Curr Opin Biotechnol 2003; 14(1): 87-95.
112. Cristofanilli M. Novel targeted therapies in inflammatory breast cancer. Cancer 2010; 116(Suppl 11): 2837-9.